Corsera wins Endpoints 11 2026 award, marking a major bet by veteran biotech leaders Meanwell and Maraganore

Corsera was announced as the winner of the Endpoints 11 2026 competition, a recognition of its scientific progress.

The win highlights the involvement of veteran biotech executives Clive Meanwell and John Maraganore, who are backing the company.

Their support signals confidence in Corsera’s approach and could attract further attention from investors and partners.